ABBV logo

AbbVie (ABBV) CAPEX

Annual CAPEX

$777.00 M
+$82.00 M+11.80%

31 December 2023

1-Year Change

+11.8%
ABBV annual capital expenditures is up +11.8% year-on-year

3-Year Change

-2.63%
ABBV annual capital expenditures is down -2.63% over the past 3 years

All-time High

$798.00 M
ABBV annual capital expenditures is currently -2.63% below its historical high of $798.00 million

Sector Rank

96.53%
ABBV annual capital expenditures is higher than 96.53% of companies in Healthcare sector
Annual FCF$22.06 B
ABBV annual free cash flow is $22.06 billion
Annual CFO$22.84 B
ABBV annual cash flow from operations is $22.84 billion
Annual CFI-$2.01 B
ABBV annual cash flow from investing activities is -$2.01 billion
Annual CFF-$17.22 B
ABBV annual cash flow from financing activities is -$17.22 billion

ABBV CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CAPEX

$249.00 M
+$8.00 M+3.32%

30 September 2024

1-Year Change

+13.7%
ABBV quarterly capital expenditures is up +13.7% year-on-year

3-Year Change

+14.75%
ABBV quarterly capital expenditures is up +14.75% over the past 3 years

All-time High

$282.00 M
ABBV quarterly capital expenditures is currently -11.70% below its historical high of $282.00 million

Sector Rank

96.59%
ABBV quarterly capital expenditures is higher than 96.59% of companies in Healthcare sector
Quarterly FCF$5.20 B
ABBV quarterly free cash flow is $5.20 billion
Quarterly CFO$5.45 B
ABBV quarterly cash flow from operations is $5.45 billion
Quarterly CFI-$8.26 B
ABBV quarterly cash flow from investing activities is -$8.26 billion
Quarterly CFF-$3.07 B
ABBV quarterly cash flow from financing activities is -$3.07 billion

ABBV Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CAPEX

$888.00 M
+$30.00 M+3.50%

30 September 2024

1-Year Change

+13.12%
ABBV TTM capital expenditures is up +13.12% year-on-year

3-Year Change

+1.02%
ABBV TTM capital expenditures is up +1.02% over the past 3 years

All-time High

$888.00 M
ABBV TTM capital expenditures is currently at an all-time high

Sector Rank

96.15%
ABBV TTM capital expenditures is higher than 96.15% of companies in Healthcare sector
TTM FCF$15.62 B
ABBV TTM free cash flow is $15.62 billion
TTM CFO$16.51 B
ABBV TTM cash flow from operations is $16.51 billion
TTM CFI-$19.75 B
ABBV TTM cash flow from investing activities is -$19.75 billion
TTM CFF-$2.80 B
ABBV TTM cash flow from financing activities is -$2.80 billion

ABBV TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABBV CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+11.8%+13.7%+13.1%
3 y3 years-2.6%+14.8%+1.0%
5 y5 years+21.8%+61.7%+73.4%

ABBV CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-2.6%+11.8%at high+74.1%at high+32.7%
5 y5 years-2.6%+40.8%-10.8%+99.2%at high+73.4%
alltimeall time-2.6%+148.6%-11.7%+1483.3%at high+816.9%

AbbVie CAPEX History

DateAnnualQuarterlyTTM
Sept 2024
-
$249.00 M(+3.3%)
$888.00 M(+3.5%)
June 2024
-
$241.00 M(+24.9%)
$858.00 M(+7.9%)
Mar 2024
-
$193.00 M(-5.9%)
$795.00 M(+2.3%)
Dec 2023
$777.00 M(+11.8%)
$205.00 M(-6.4%)
$777.00 M(-1.0%)
Sept 2023
-
$219.00 M(+23.0%)
$785.00 M(+5.7%)
June 2023
-
$178.00 M(+1.7%)
$743.00 M(+4.9%)
Mar 2023
-
$175.00 M(-17.8%)
$708.00 M(+1.9%)
Dec 2022
$695.00 M(-11.7%)
$213.00 M(+20.3%)
$695.00 M(+3.9%)
Sept 2022
-
$177.00 M(+23.8%)
$669.00 M(-5.6%)
June 2022
-
$143.00 M(-11.7%)
$709.00 M(-6.8%)
Mar 2022
-
$162.00 M(-13.4%)
$761.00 M(-3.3%)
Dec 2021
$787.00 M(-1.4%)
$187.00 M(-13.8%)
$787.00 M(-10.5%)
Sept 2021
-
$217.00 M(+11.3%)
$879.00 M(0.0%)
June 2021
-
$195.00 M(+3.7%)
$879.00 M(+2.1%)
Mar 2021
-
$188.00 M(-32.6%)
$861.00 M(+7.9%)
Dec 2020
$798.00 M(+44.6%)
$279.00 M(+28.6%)
$798.00 M(+17.0%)
Sept 2020
-
$217.00 M(+22.6%)
$682.00 M(+10.2%)
June 2020
-
$177.00 M(+41.6%)
$619.00 M(+8.6%)
Mar 2020
-
$125.00 M(-23.3%)
$570.00 M(+3.3%)
Dec 2019
$552.00 M(-13.5%)
$163.00 M(+5.8%)
$552.00 M(+7.8%)
Sept 2019
-
$154.00 M(+20.3%)
$512.00 M(-20.0%)
June 2019
-
$128.00 M(+19.6%)
$640.00 M(+2.2%)
Mar 2019
-
$107.00 M(-13.0%)
$626.00 M(-1.9%)
Dec 2018
$638.00 M(+20.6%)
$123.00 M(-56.4%)
$638.00 M(-8.5%)
Sept 2018
-
$282.00 M(+147.4%)
$697.00 M(+28.8%)
June 2018
-
$114.00 M(-4.2%)
$541.00 M(-2.2%)
Mar 2018
-
$119.00 M(-34.6%)
$553.00 M(+4.5%)
Dec 2017
$529.00 M
$182.00 M(+44.4%)
$529.00 M(+14.8%)
DateAnnualQuarterlyTTM
Sept 2017
-
$126.00 M(0.0%)
$461.00 M(+2.9%)
June 2017
-
$126.00 M(+32.6%)
$448.00 M(-1.1%)
Mar 2017
-
$95.00 M(-16.7%)
$453.00 M(-5.4%)
Dec 2016
$479.00 M(-10.0%)
$114.00 M(+0.9%)
$479.00 M(-6.1%)
Sept 2016
-
$113.00 M(-13.7%)
$510.00 M(-2.7%)
June 2016
-
$131.00 M(+8.3%)
$524.00 M(+3.1%)
Mar 2016
-
$121.00 M(-16.6%)
$508.00 M(-4.5%)
Dec 2015
$532.00 M(-13.1%)
$145.00 M(+14.2%)
$532.00 M(-1.5%)
Sept 2015
-
$127.00 M(+10.4%)
$540.00 M(-8.9%)
June 2015
-
$115.00 M(-20.7%)
$593.00 M(-4.4%)
Mar 2015
-
$145.00 M(-5.2%)
$620.00 M(+1.3%)
Dec 2014
$612.00 M(+24.6%)
$153.00 M(-15.0%)
$612.00 M(+0.3%)
Sept 2014
-
$180.00 M(+26.8%)
$610.00 M(+8.3%)
June 2014
-
$142.00 M(+3.6%)
$563.00 M(+4.3%)
Mar 2014
-
$137.00 M(-9.3%)
$540.00 M(+10.0%)
Dec 2013
$491.00 M(+47.4%)
$151.00 M(+13.5%)
$491.00 M(+12.9%)
Sept 2013
-
$133.00 M(+11.8%)
$435.00 M(+53.2%)
June 2013
-
$119.00 M(+35.2%)
$284.00 M(+9.7%)
Mar 2013
-
$88.00 M(-7.4%)
$259.00 M(-22.2%)
Dec 2012
$333.00 M(-6.5%)
$95.00 M(-627.8%)
$333.00 M(-2.9%)
Sept 2012
-
-$18.00 M(-119.1%)
$342.89 M(-19.1%)
June 2012
-
$94.00 M(-42.0%)
$424.06 M(+0.7%)
Mar 2012
-
$162.00 M(+54.4%)
$421.15 M(+18.3%)
Dec 2011
$356.00 M(-20.5%)
$104.89 M(+66.1%)
$356.00 M(+41.8%)
Sept 2011
-
$63.17 M(-30.7%)
$251.10 M(+33.6%)
June 2011
-
$91.09 M(-5.9%)
$187.94 M(+94.1%)
Mar 2011
-
$96.85 M
$96.85 M
Dec 2010
$448.00 M(+43.3%)
-
-
Dec 2009
$312.56 M
-
-

FAQ

  • What is AbbVie annual capital expenditures?
  • What is the all time high annual CAPEX for AbbVie?
  • What is AbbVie annual CAPEX year-on-year change?
  • What is AbbVie quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for AbbVie?
  • What is AbbVie quarterly CAPEX year-on-year change?
  • What is AbbVie TTM capital expenditures?
  • What is the all time high TTM CAPEX for AbbVie?
  • What is AbbVie TTM CAPEX year-on-year change?

What is AbbVie annual capital expenditures?

The current annual CAPEX of ABBV is $777.00 M

What is the all time high annual CAPEX for AbbVie?

AbbVie all-time high annual capital expenditures is $798.00 M

What is AbbVie annual CAPEX year-on-year change?

Over the past year, ABBV annual capital expenditures has changed by +$82.00 M (+11.80%)

What is AbbVie quarterly capital expenditures?

The current quarterly CAPEX of ABBV is $249.00 M

What is the all time high quarterly CAPEX for AbbVie?

AbbVie all-time high quarterly capital expenditures is $282.00 M

What is AbbVie quarterly CAPEX year-on-year change?

Over the past year, ABBV quarterly capital expenditures has changed by +$30.00 M (+13.70%)

What is AbbVie TTM capital expenditures?

The current TTM CAPEX of ABBV is $888.00 M

What is the all time high TTM CAPEX for AbbVie?

AbbVie all-time high TTM capital expenditures is $888.00 M

What is AbbVie TTM CAPEX year-on-year change?

Over the past year, ABBV TTM capital expenditures has changed by +$103.00 M (+13.12%)